Page last updated: 2024-11-10

caryophyllene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

(-)-beta-caryophyllene : A beta-caryophyllene in which the stereocentre adjacent to the exocyclic double bond has S configuration while the remaining stereocentre has R configuration. It is the most commonly occurring form of beta-caryophyllene, occurring in many essential oils, particularly oil of cloves. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

beta-caryophyllene : A sesquiterpene with a [7.2.0]-bicyclic structure comprising fused 9- and 4-membered rings, with a trans-ring junction, a trans-double bond between the 4- and 5-positions of the 9-membered ring, a methylidene group at position 9, and methyl groups at positions 3, 11, and 11. The most commonly occurring form is the (1R,9S)-(-)-enantiomer, which is found in many essential oils, particularly clove oil. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

cannabinoid : A diverse group of pharmacologically active secondary metabolite characteristic to Cannabis plant as well as produced naturally in the body by humans and animals. Cannabinoids contain oxygen as a part of the heterocyclic ring or in the form of various functional groups. They are subdivided on the basis of their origin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

caryophyllene: RN given refers to cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Copaibagenus[no description available]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID5281515
CHEMBL ID445740
CHEBI ID10357
CHEBI ID63191
MeSH IDM0083228
PubMed CID5322111
MeSH IDM0083228

Synonyms (133)

Synonym
.beta.-(e)-caryophyllene
e-.beta.-caryophyllene
.beta.-caryophyllen
nsc-11906
.beta.-caryophyllene, (-)
.beta.-caryophyllene
trans-caryophyllene
l-caryophyllene
(-)-caryophyllene
bicyclo(7.2.0)undec-4-ene, 4,11,11-trimethyl-8-methylene-, (1r-(1r*,4e,9s*))-
beta-caryophyllen
2-methylene-6,10,10-trimethylbicyclo(7.2.0)undec-5-ene
nsc 11906
8-methylene-4,11,11-(trimethyl)bicyclo(7.2.0)undec-4-ene
fema no. 2252
bicyclo(7.2.0)undec-4-ene, 8-methylene-4,11,11-trimethyl-, (e)-(1r,9s)-(-)-
einecs 201-746-1
ai3-36121
bicyclo(7.2.0)undec-4-ene, 4,11,11-trimethyl-8-methylene-, (1r,4e,9s)-
4,11,11-trimethyl-8-methylenebicyclo(7.2.0)undec-4-ene, (1r-(1r*,4e,9s))-
copaiba
(-)-beta-caryophyllene
C09629
beta-caryophyllene
beta-caryophyllene, >=80%, fcc, fg
NCGC00142620-01
(-)-trans-caryophyllene
(1r,4e,9s)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene
8-methylene-4,11,11-(trimethyl)bicyclo[7.2.0]undec-4-ene
(e)-beta-caryophylene
trans-beta-caryophyllene
(e)-beta-caryophyllene
(-)-trans-caryophyllene, >=98.5% (sum of enantiomers, gc)
LMPR0103120001
CHEMBL445740
trans-.beta.-caryophyllene
chebi:10357 ,
beta-caryophylene
(-)-(e)-caryophyllene
(1r,4e,9s)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene
trans-(1r,9s)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene
cannabinoid
tox21_301497
cas-87-44-5
dtxsid8024739 ,
dtxcid304739
NCGC00255159-01
(1s,9r)-6,10,10-trimethyl-2-methylenebicyclo[7.2.0]undec-5-ene
bicyclo[7.2.0]undec-4-ene, 8-methylene-4,11,11-trimethyl-, (e)-(1r,9s)-(-)-
bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, [1r- (1r*,4e,9s*)]-
(1r,4e,9s)-4,11,11-trimethyl-8-methylene-bicyclo[7.2.0]undec-4-ene
unii-bhw853au9h
bhw853au9h ,
(e)-caryophyllene
ccris 8094
e-caryophyllene
(-)-e-caryophyllene
caryophyllene [mi]
beta-caryophyllene [inci]
(1r,4e,9s)-4,11,11-trimethyl-8-methylenebicyclo(7.2.0)undec-4-ene
beta-caryophyllene [fcc]
.beta.-caryophyllene [fhfi]
S6058
AKOS024283988
bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, (e)-(1r,9s)-(-)-
.beta.-trans-caryophyllene
caryophyllene, (e)
caryophyllene b
8-methylene-4,11,11-(trimethyl)bicyclo(7.2.0)undec-4-ene, (1r,4e,9s)-
W-109317
mfcd00075925
(-)-trans-caryophyllene, analytical standard
b-caryophyllene
beta-trans-caryophyllene
beta-caryophillene
tincturoid
beta-cariofillene
e-beta-caryophyllene
beta-(e)-caryophyllene
g-caryophyllene
(-)-i(2)-caryophyllene
HY-N1415
CS-0016839
Q421614
(?)-b-caryophyllene
(?)-trans-caryophyllene
beta-caryophyllene 2000 microg/ml in acetonitrile
bdbm50529607
CHEBI:63191 ,
(1r,4e,9s)-4,11,11-trimethyl-8-methylidenebicyclo(7.2.0)undec-4-ene
trans-(1r,9s)-4,11,11-trimethyl-8-methylenebicyclo(7.2.0)undec-4-ene
bicyclo(7.2.0)undec-4-ene, 4,11,11-trimethyl-8-methylene-, (e)-(1r,9s)-(-)-
bicyclo(7.2.0)undec-4-ene, 4,11,11-trimethyl-8-methylene-, (1r-(1r*,4e,9s*)-
1-caryophyllene
caryophyllene hg
cariofileno
cb2 receptor
11car7501
trans caryophyllene
p198906
12 - analysis of terpenes
02 - terpenes
CLOVE TERPENES ,
caryophyllene beta natural
caryophyllene 917
clove terpene derivative
bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, (1r,4e,9s)-
cis-.beta.-caryophyllene
.gamma.-caryophyllene
bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, [1r-(1r*,4e,9s*)]-
nsc11906 ,
bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-,[1r-(1r*,4z,9s*)]-
4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene
caryophyllene
87-44-5
bicyclo(7.2.0)undec-4-ene, 4,11,11-trimethyl-8-methylene-
(4z)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene
STK017347
BBL001767
4,11,11-trimethyl-8-methylenebicyclo(7.2.0)undec-4-ene
13877-93-5
(5z)-6,10,10-trimethyl-2-methylidenebicyclo[7.2.0]undec-5-ene
AKOS005378035
b-caryophyllene fcc
NPNUFJAVOOONJE-WDZFZDKYSA-N
.beta.-cis-caryophyllene
4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene #
(z)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene
(z)-4,11,11-trimethyl-8-methylene-bicyclo[7.2.0]undec-4-ene, aldrichcpr
cis-4,11,11-trimethyl-8-methylene-bicyclo(7.2.0)undeca-4-ene
4,11,11-trimethyl-8-methylene-bicyclo[7.2.0]undec-4-ene
VS-00870
54061-81-3

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"9 µg cm(-3) ) was the most toxic compound, followed by citronellyl acetate (16."( Fumigant toxicity of lemon eucalyptus oil constituents to acaricide-susceptible and acaricide-resistant Tetranychus urticae.
Ahn, YJ; Choi, BR; Han, J; Kim, SI; Lee, SG, 2011
)
0.37
" The no observed adverse effect level was the highest dosage level administered of 700 mg/kg body weight/d for both male and female rats."( Toxicological Evaluation of β-Caryophyllene Oil: Subchronic Toxicity in Rats.
Carroll, B; Levy, R; Schmitt, D, 2016
)
0.43
" There was absence of adverse clinical signs and mortality in any animal subjected to acute and repeated-dose toxicity study."( Non-clinical toxicity of β-caryophyllene, a dietary cannabinoid: Absence of adverse effects in female Swiss mice.
da Silva, APDSCL; de Castro Almeida, FR; Feitosa, CM; Machado, KC; Oliveira, GLDS, 2018
)
0.48
" The environmental endpoints were evaluated; β-caryophyllene was found not to be Persistent, Bioaccumulative, and Toxic (PBT) as per the International Fragrance Association (IFRA) Environmental Standards, and its risk quotients, based on its current volume of use in Europe and North America (i."( RIFM fragrance ingredient safety assessment, β-caryophyllene, CAS Registry Number 87-44-5.
Api, AM; Belsito, D; Botelho, D; Bruze, M; Burton, GA; Buschmann, J; Cancellieri, MA; Dagli, ML; Date, M; Dekant, W; Deodhar, C; Fryer, AD; Jones, L; Joshi, K; Kumar, M; Lapczynski, A; Lavelle, M; Lee, I; Liebler, DC; Moustakas, H; Na, M; Penning, TM; Ritacco, G; Romine, J; Sadekar, N; Schultz, TW; Selechnik, D; Siddiqi, F; Sipes, IG; Sullivan, G; Thakkar, Y; Tokura, Y, 2022
)
0.72

Bioavailability

ExcerptReferenceRelevance
" The aim of this study is to investigate and compare the oral bioavailability and the pharmacokinetics of free BCP and BCP/β-CD inclusion complex after a single oral dose of 50mg/kg on rats."( Physicochemical characterization and pharmacokinetics evaluation of β-caryophyllene/β-cyclodextrin inclusion complex.
Cao, D; Fan, G; Liu, H; Qi, T; Qi, Y; Tang, Y; Yang, G, 2013
)
0.39
" Despite this recognized potential, this hydrophobic compound is a volatile and acid-sensitive sesquiterpene that readily oxidizes when exposed to air, and has low bioavailability in oral formulations."( β-caryophyllene Delivery Systems: Enhancing the Oral Pharmacokinetic and Stability.
Figueiras, A; Nunes, LCC; Oliveira, TC; R Júnior, LM; Santos, PS, 2018
)
0.48

Dosage Studied

ExcerptRelevanceReference
" Parallel dose-response curves for the two enantiomers were obtained by direct stimulations."( Receptor neuron discrimination of the germacrene D enantiomers in the moth Helicoverpa armigera.
Borg-Karlson, AK; Mustaparta, H; Stranden, M, 2002
)
0.31
" In addition, fall armyworm larvae show a preference for Tx601 whorl tissue over Mp708 tissue, and the dosage of Tx601 whorl with (E)-beta-caryophyllene repels the fall armyworm."( A maize line resistant to herbivory constitutively releases (E) -beta-caryophyllene.
Brown, AE; Luthe, DS; Sandoya, GV; Shivaji, R; Smith, CL; Smith, WE; Sparks, DL; Williams, WP, 2012
)
0.38
" The no observed adverse effect level was the highest dosage level administered of 700 mg/kg body weight/d for both male and female rats."( Toxicological Evaluation of β-Caryophyllene Oil: Subchronic Toxicity in Rats.
Carroll, B; Levy, R; Schmitt, D, 2016
)
0.43
" Experiments established the dose-response effects of BCP and pharmacological mechanisms of the antinociceptive action dependent on CB2 and opioid receptors."( Antinociceptive and chondroprotective effects of prolonged β-caryophyllene treatment in the animal model of osteoarthritis: Focus on tolerance development.
Kac, P; Kędziora, M; Mlost, J; Starowicz, K, 2022
)
0.72
" aureus and incubated with treatment for cytokine dosage and gene expression analysis."( β-caryophyllene and docosahexaenoic acid, isolated or associated, have potential antinociceptive and anti-inflammatory effects in vitro and in vivo.
Campos, GB; da Silva, LSC; das Neves Selis, N; Marques, LM; Morbeck, LLB; Oliveira, HBM; Reis, MM; Sampaio, BA; Santos, TC; Sousa, LFB; Timenetsky, J; Viana, JCS; Yatsuda, R, 2022
)
0.72
" First, we determined the analgesic effect of CBD and BCP individually by establishing dose-response studies."( Cannabidiol and Beta-Caryophyllene in Combination: A Therapeutic Functional Interaction.
Benamar, K; Blanton, H; Duong, J; Yin, L, 2022
)
0.72
" BCP was administered orally at a dosage of 200 mg/kg for seven consecutive days prior to the scheduled surgery."( Effects of oral β-caryophyllene (BCP) treatment on perioperative neurocognitive disorders: Attenuation of neuroinflammation associated with microglial activation and reinforcement of autophagy activity in aged mice.
Bai, N; Chen, F; Hao, Y; He, Y; Lu, K; Wang, H; Yue, F, 2023
)
0.91
" Mouse proteome profiler cytokine/chemokine array revealed upregulation of complement C5/5a (anaphylatoxin), soluble intracellular adhesion molecule-1 (sICAM-1) and IL-1 receptor antagonist (IL-1RA) in animals dosed with β-CP (10 mg/mL)."( Epicutaneous Sensitization to the Phytocannabinoid β-Caryophyllene Induces Pruritic Inflammation.
Baltazar, CT; Inan, S; Javed, E; Nayak, AP; Peruggia, GA; Ward, SJ, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
non-steroidal anti-inflammatory drugAn anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.
fragranceA substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
insect attractantA chemical that attracts insects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
beta-caryophylleneA sesquiterpene with a [7.2.0]-bicyclic structure comprising fused 9- and 4-membered rings, with a trans-ring junction, a trans-double bond between the 4- and 5-positions of the 9-membered ring, a methylidene group at position 9, and methyl groups at positions 3, 11, and 11. The most commonly occurring form is the (1R,9S)-(-)-enantiomer, which is found in many essential oils, particularly clove oil.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
u03B2-caryophyllene biosynthesis85
oleoresin sesquiterpene volatiles biosynthesis58
superpathway of oleoresin turpentine biosynthesis1617
Oleoresin sesquiterpene volatiles biosynthesis07

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency69.16660.000229.305416,493.5996AID743075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cannabinoid receptor 2 Homo sapiens (human)Ki0.15000.00000.415610.0000AID1612079
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cannabinoid receptor 2 Homo sapiens (human)EC50 (µMol)1.90000.00030.15173.2800AID1612080
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (12)

Processvia Protein(s)Taxonomy
response to amphetamineCannabinoid receptor 2 Homo sapiens (human)
inflammatory responseCannabinoid receptor 2 Homo sapiens (human)
immune responseCannabinoid receptor 2 Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerCannabinoid receptor 2 Homo sapiens (human)
leukocyte chemotaxisCannabinoid receptor 2 Homo sapiens (human)
negative regulation of synaptic transmission, GABAergicCannabinoid receptor 2 Homo sapiens (human)
response to lipopolysaccharideCannabinoid receptor 2 Homo sapiens (human)
negative regulation of mast cell activationCannabinoid receptor 2 Homo sapiens (human)
cannabinoid signaling pathwayCannabinoid receptor 2 Homo sapiens (human)
negative regulation of action potentialCannabinoid receptor 2 Homo sapiens (human)
regulation of metabolic processCannabinoid receptor 2 Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayCannabinoid receptor 2 Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
protein bindingCannabinoid receptor 2 Homo sapiens (human)
cannabinoid receptor activityCannabinoid receptor 2 Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
plasma membraneCannabinoid receptor 2 Homo sapiens (human)
dendriteCannabinoid receptor 2 Homo sapiens (human)
extrinsic component of cytoplasmic side of plasma membraneCannabinoid receptor 2 Homo sapiens (human)
perikaryonCannabinoid receptor 2 Homo sapiens (human)
endoplasmic reticulumCannabinoid receptor 2 Homo sapiens (human)
plasma membraneCannabinoid receptor 2 Homo sapiens (human)
cytoplasmCannabinoid receptor 2 Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (45)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1612080Agonist activity at recombinant human Cb2 receptor expressed in CHOK1 cells assessed as inhibition of forskolin-stimulated cAMP levels measured up to 30 mins by luminescence assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus.
AID669299Antitrypanosomal activity against Trypanosoma cruzi Y amastigotes infected in monkey LLC-MK2 cells after 96 hrs by Geimsa staining method2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID669316Antitrypanosomal activity against Trypanosoma cruzi Y epimastigotes assessed as formation of concentric membranous vacuoles at compound IC50 concentration after 96 hrs by transmission electron microscopic analysis2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID1111946Insecticidal activity against acaricide-susceptible female Tetranychus urticae KST (two-spotted spider mite) in kidney bean assessed as mortality in 3 cm disks measured after 24 hr exposure by vapour-phase mortality bioassay2011Pest management science, Dec, Volume: 67, Issue:12
Fumigant toxicity of lemon eucalyptus oil constituents to acaricide-susceptible and acaricide-resistant Tetranychus urticae.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID669298Antitrypanosomal activity against Trypanosoma cruzi Y trymastigotes infected in monkey LLC-MK2 cells after 24 hrs by Brenner counter method2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID336297Induction of cytosolic Glutathione S-transferase activity per mg of protein in A/J mouse liver at 20 mg, po for once every 2 days for total three doses measured after 24 hrs of last dose1992Journal of natural products, Jul, Volume: 55, Issue:7
Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents.
AID1599306Antiviral activity against DENV22019European journal of medicinal chemistry, Aug-15, Volume: 176Recent update on anti-dengue drug discovery.
AID669304Antitrypanosomal activity against Trypanosoma cruzi Y trymastigotes infected in monkey LLC-MK2 cells after 24 hrs by Brenner counter method in presence of copalic2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID336300Ratio of drug to control in induction of cytosolic Glutathione S-transferase activity per mg of protein in A/J mouse liver at 20 mg, po for once every 2 days for total three doses measured after 24 hrs of last dose1992Journal of natural products, Jul, Volume: 55, Issue:7
Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents.
AID669305Antitrypanosomal activity against Trypanosoma cruzi Y trymastigotes infected in monkey LLC-MK2 cells after 24 hrs by Brenner counter method in presence of beta-hydroxycopalic2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID669308Antitrypanosomal activity against Trypanosoma cruzi Y epimastigotes assessed as gated cells in lower right quadrant at 400 uM after 3 hrs by propidium iodide staining-based flow cytometric analysis (Rvb = 5.41%)2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID669302Selectivity ratio of CC50 for monkey LLC-MK2 cells to IC50 for Trypanosoma cruzi Y amastigotes2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID378070Inhibition of spontaneous contraction in guinea pig ileum2006Journal of natural products, Aug, Volume: 69, Issue:8
Qualitative and quantitative analysis of the active components of the essential oil from Brickellia veronicaefolia by nuclear magnetic resonance spectroscopy.
AID669296Antitrypanosomal activity against Trypanosoma cruzi Y infected in monkey LLC-MK2 cells assessed as reduction in number of amastigotes after 96 hrs by Geimsa staining method2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID669301Toxicity in human RBC assessed as hemolysis after 3 hrs2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID1111943Insecticidal activity against pyridaben-resistant female Tetranychus urticae PRT-53 (two-spotted spider mite) in kidney bean assessed as mortality in 3 cm disks measured after 24 hr exposure by vapour-phase mortality bioassay2011Pest management science, Dec, Volume: 67, Issue:12
Fumigant toxicity of lemon eucalyptus oil constituents to acaricide-susceptible and acaricide-resistant Tetranychus urticae.
AID336299Induction of cytosolic Glutathione S-transferase activity per mg of protein in A/J mouse forestomach at 20 mg, po for once every 2 days for total three doses measured after 24 hrs of last dose1992Journal of natural products, Jul, Volume: 55, Issue:7
Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents.
AID669315Antitrypanosomal activity against Trypanosoma cruzi Y epimastigotes assessed as kinetoplast disorganisation at compound IC50 concentration after 96 hrs by transmission electron microscopic analysis2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID336301Ratio of drug to control in induction of cytosolic Glutathione S-transferase activity per mg of protein in A/J mouse small bowel mucosa at 20 mg, po for once every 2 days for total three doses measured after 24 hrs of last dose1992Journal of natural products, Jul, Volume: 55, Issue:7
Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents.
AID669300Cytotoxicity against monkey LLC-MK2 cells after 96 hrs by sulforhodamine B assay2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID1111944Insecticidal activity against fenpropathrin-resistant female Tetranychus urticae FRT-53 (two-spotted spider mite) in kidney bean assessed as mortality in 3 cm disks measured after 24 hr exposure by vapour-phase mortality bioassay2011Pest management science, Dec, Volume: 67, Issue:12
Fumigant toxicity of lemon eucalyptus oil constituents to acaricide-susceptible and acaricide-resistant Tetranychus urticae.
AID669309Antitrypanosomal activity against Trypanosoma cruzi Y epimastigotes assessed as gated cells in upper right quadrant at 400 uM after 3 hrs by propidium iodide staining-based flow cytometric analysis (Rvb = 1.40%)2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID1612079Displacement of [3H]CP55940 from human CB2 expressed in CHOK1 cell membranes after 2 hrs by liquid scintillation counting method2018European journal of medicinal chemistry, Sep-05, Volume: 157Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID669306Antitrypanosomal activity against Trypanosoma cruzi Y epimastigotes assessed as lipid peroxidation at 400 uM after 6 hrs2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID1081538Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 24 hr assessed as reduction in larval motility2010Journal of agricultural and food chemistry, Jul-14, Volume: 58, Issue:13
Phytochemistry and nematicidal activity of the essential oils from 8 Greek Lamiaceae aromatic plants and 13 terpene components.
AID669310Antitrypanosomal activity against Trypanosoma cruzi Y epimastigotes assessed as gated cells in upper left quadrant at 400 uM after 3 hrs by propidium iodide staining-based flow cytometric analysis (Rvb = 3.76%)2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID1111945Insecticidal activity against chlorfenapyr-resistant female Tetranychus urticae CRT-53 (two-spotted spider mite) in kidney bean assessed as mortality in 3 cm disks measured after 24 hr exposure by vapour-phase mortality bioassay2011Pest management science, Dec, Volume: 67, Issue:12
Fumigant toxicity of lemon eucalyptus oil constituents to acaricide-susceptible and acaricide-resistant Tetranychus urticae.
AID669311Antitrypanosomal activity against Trypanosoma cruzi Y epimastigotes assessed as gated cells in lower left quadrant at 400 uM after 3 hrs by rhodamine 123 staining-based flow cytometric analysis (Rvb = 2.40%)2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID669307Antitrypanosomal activity against Trypanosoma cruzi Y epimastigotes assessed as gated cells in lower left quadrant at 400 uM after 3 hrs by propidium iodide staining-based flow cytometric analysis (Rvb = 89.35%)2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID1081539Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 48 hr assessed as reduction in larval motility2010Journal of agricultural and food chemistry, Jul-14, Volume: 58, Issue:13
Phytochemistry and nematicidal activity of the essential oils from 8 Greek Lamiaceae aromatic plants and 13 terpene components.
AID669314Antitrypanosomal activity against Trypanosoma cruzi Y epimastigotes assessed as gated cells in upper left quadrant at 400 uM after 3 hrs by rhodamine 123 staining-based flow cytometric analysis (Rvb = 1.54%)2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID669297Antitrypanosomal activity against Trypanosoma cruzi Y epimastigotes after 96 hrs by neubauer chamber2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID1081540Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) larvae immersed in compound solution for 96 hr assessed as reduction in larval motility2010Journal of agricultural and food chemistry, Jul-14, Volume: 58, Issue:13
Phytochemistry and nematicidal activity of the essential oils from 8 Greek Lamiaceae aromatic plants and 13 terpene components.
AID1070523Partition coefficient, log K of the compound in n-hexane/methyl tert-butylether/acetonitrile 10:1:10 solvent system by HSCCC/EECCC analysis2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Airborne antituberculosis activity of Eucalyptus citriodora essential oil.
AID669313Antitrypanosomal activity against Trypanosoma cruzi Y epimastigotes assessed as gated cells in upper right quadrant at 400 uM after 3 hrs by rhodamine 123 staining-based flow cytometric analysis (Rvb = 94.94%)2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
AID336298Induction of cytosolic Glutathione S-transferase activity per mg of protein in A/J mouse small bowel mucosa at 20 mg, po for once every 2 days for total three doses measured after 24 hrs of last dose1992Journal of natural products, Jul, Volume: 55, Issue:7
Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents.
AID1111942Insecticidal activity against abamectin-resistant female Tetranychus urticae ART-53 (two-spotted spider mite) in kidney bean assessed as mortality in 3 cm disks measured after 24 hr exposure by vapour-phase mortality bioassay2011Pest management science, Dec, Volume: 67, Issue:12
Fumigant toxicity of lemon eucalyptus oil constituents to acaricide-susceptible and acaricide-resistant Tetranychus urticae.
AID336302Ratio of drug to control in induction of cytosolic Glutathione S-transferase activity per mg of protein in A/J mouse forestomach at 20 mg, po for once every 2 days for total three doses measured after 24 hrs of last dose1992Journal of natural products, Jul, Volume: 55, Issue:7
Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents.
AID332912Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method1994Journal of natural products, Jan, Volume: 57, Issue:1
Naturally occurring antiacne agents.
AID669312Antitrypanosomal activity against Trypanosoma cruzi Y epimastigotes assessed as gated cells in lower right quadrant at 400 uM after 3 hrs by rhodamine 123 staining-based flow cytometric analysis (Rvb = 1.12%)2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (642)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (1.40)18.7374
1990's15 (2.34)18.2507
2000's94 (14.64)29.6817
2010's380 (59.19)24.3611
2020's144 (22.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 74.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index74.82 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index124.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (74.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials4 (0.62%)5.53%
Reviews2 (18.18%)6.00%
Reviews16 (2.48%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational1 (0.16%)0.25%
Other9 (81.82%)84.16%
Other624 (96.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effectiveness of a Combined Therapy With Paravertebral Oxygen-ozone Injections and Topical Patch Containing Cannabidiol and β-Caryophyllene for Treatment of Neck Pain: a Prospective, Randomized, Controlled Trial. [NCT06099171]Phase 352 participants (Anticipated)Interventional2024-02-01Not yet recruiting
Analgesic and Subjective Effects of Terpenes Administered Alone and in Combination With THC [NCT04451863]Phase 145 participants (Anticipated)Interventional2021-12-15Recruiting
Acute Changes In Thermal Pain Response Following Single Oral Dose of Beta-Cary [NCT04794205]Phase 1/Phase 20 participants (Actual)Interventional2021-09-30Withdrawn(stopped due to Delayed project onset; PI determined pilot data could be collected at a later date.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]